Quantamental Technologies’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,684
Closed -$273K 590
2023
Q1
$273K Buy
15,684
+3,242
+26% +$46.2K 0.15% 259
2022
Q4
$115K Buy
+12,442
New +$116K 0.05% 405
2019
Q1
Sell
-6,055
Closed -$76K 1691
2018
Q4
$76K Buy
+6,055
New +$90.2K 0.05% 651

Other funds holding NEO

Quantamental Technologies's NEO Position: Q2 2023 in Review

Quantamental Technologies sold out of NeoGenomics (NEO) in Q2 2023, closing a stake of 15,684 shares — an estimated $273K sold.

Quantamental Technologies first reported a position in NEO in Q4 2018 and held it in 3 quarters. The position peaked at $273K in Q1 2023. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2023.

  • Quantamental Technologies reported no remaining NeoGenomics position as of Q2 2023 after selling out during the quarter.
  • Quantamental Technologies sold 15,684 NeoGenomics shares in Q2 2023, an estimated $273K.
  • Quantamental Technologies first reported a position in NeoGenomics in Q4 2018 and held it in 3 quarters.
  • Quantamental Technologies's NeoGenomics position peaked at $273K in Q1 2023.
  • 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.

Based on Quantamental Technologies's 13F filing for Q2 2023, filed 14 Aug 2023.